PARMODIA Trademark

Trademark Overview

On Monday, March 6, 2017, a trademark application was filed for PARMODIA with the United States Patent and Trademark Office. The USPTO has given the PARMODIA trademark a serial number of 79212518. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 31, 2024. This trademark is owned by KOWA COMPANY, LTD.. The PARMODIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases; pharmaceutical preparations for the treatment of fatty liver and steatohepatitis

General Information

Serial Number79212518
Word MarkPARMODIA
Filing DateMonday, March 6, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 31, 2024
Registration Number5332279
Registration DateTuesday, November 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases; pharmaceutical preparations for the treatment of fatty liver and steatohepatitis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 31, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKOWA COMPANY, LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNagoya-shi, Aichi-ken 460-8625
JP
Party NameKOWA COMPANY, LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameKOWA COMPANY, LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Thursday, July 13, 2017SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, July 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 14, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, August 9, 2017NOTICE OF PUBLICATION
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Friday, January 26, 2018NOTIFICATION PROCESSED BY IB
Wednesday, July 19, 2017ASSIGNED TO EXAMINER
Friday, July 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 25, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, August 29, 2017PUBLISHED FOR OPPOSITION
Thursday, December 14, 2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, December 27, 2017GENERIC MADRID TRANSACTION CREATED
Wednesday, December 27, 2017GENERIC MADRID TRANSACTION SENT TO IB
Sunday, May 30, 2021NOTIFICATION PROCESSED BY IB
Sunday, October 24, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Sunday, October 24, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Sunday, October 24, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Friday, October 29, 2021NOTIFICATION PROCESSED BY IB
Wednesday, November 10, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, April 11, 2023CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Wednesday, July 12, 2023CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, April 12, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 24, 2023CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, May 31, 2024CANCELLED SECTION 71
Wednesday, April 16, 2025INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Wednesday, April 16, 2025GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, April 16, 2025GENERIC MADRID TRANSACTION CREATED
Friday, January 31, 2025TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, July 24, 2023INTERNATIONAL REGISTRATION RENEWED

Related Keywords

parmodia pharmaceutical treatment diseases preparations liver steatohepatitis fatty system circulatory diabetes